India's Dhunseri Group to expand packaging films business
India-based Dhunseri Group is set to invest over Rs22bn ($254.4m) by the financial year 2028-29 to enhance its flexible packaging films business through both greenfield and brownfield projects, says Business Standard.
The investment aims to expand production capacity and cater to the growing market demand.
For the greenfield project in Kathua, Jammu and Kashmir, the group has earmarked an investment of about Rs12.4bn. Additionally, approximately Rs10bn will be allocated for the brownfield project at Panagarh in West Bengal.
These expansions are expected to be carried out by Dhunseri Poly Films (DPFPL), a wholly-owned subsidiary of Dhunseri Ventures.
Dhunseri Poly Films will expand its operations at Panagarh by installing at least two new production lines, one for biaxially oriented polyethylene terephthalate and another for biaxially oriented polypropylene (BOPP). The company already operates a unit at Panagarh.
The capital expenditure for the new lines at the Panagarh facility is expected to be financed with a debt-equity ratio of 70:30. These lines are expected to be operational by 2029.
The Panagarh plant, which commenced commercial production in December 2023, is now poised for further growth.
The company will add two BOPP plants at Kathua. The commercial production from the greenfield plant at Kathua is expected to commence in 2027.
Dhunseri Poly Films serves the domestic market while also exporting to Europe, Bangladesh, and Nepal, with these regions being the major overseas markets.
For the financial year 2025, Dhunseri Ventures reported a net profit of Rs142.9bn and a revenue of Rs480.4bn, indicating a strong financial position to support the planned investments.
"India's Dhunseri Group to expand packaging films business" was originally created and published by Packaging Gateway, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Here's Why Marvell Technology (MRVL) Traded Down in Q1
Fidelity Investments, an investment management company, recently released its 'Fidelity Dividend Growth Fund' first quarter 2025 investor letter. A copy of the letter can be downloaded here. Fidelity Dividend Growth Fund is a diversified domestic equity strategy with a focus on large-cap core. The portfolio invests in large and mid-cap firms with potential for sustainable dividend growth. The fund's Retail Class shares returned -5.29% in the first quarter, underperforming the -4.27% return of the benchmark S&P 500 index. In the first quarter, the post-election anticipation was replaced by investor concerns regarding the impacts of several actions from the new administration, disruptions to government programs, and rising uncertainty caused by changing policy priorities, particularly in trade tariffs. In addition, you can check the fund's top 5 holdings to know its best picks in 2025. In its first-quarter 2025 investor letter, Fidelity Dividend Growth Fund highlighted stocks such as Marvell Technology, Inc. (NASDAQ:MRVL). Marvell Technology, Inc. (NASDAQ:MRVL) provides semiconductor solutions for data infrastructure. The one-month return of Marvell Technology, Inc. (NASDAQ:MRVL) was 30.10%, and its shares gained 12.63% of their value over the last 52 weeks. On June 26, 2025, Marvell Technology, Inc. (NASDAQ:MRVL) stock closed at $79.97 per share, with a market capitalization of $68.95 billion. Fidelity Dividend Growth Fund stated the following regarding Marvell Technology, Inc. (NASDAQ:MRVL) in its Q1 2025 investor letter: "At the stock level, out-of-benchmark exposure to Marvell Technology, Inc. (NASDAQ:MRVL) topped our list of relative detractors. The stock returned-43% for the past three months. In early March, the provider of data infrastructure and semiconductor solutions reported slightly better than-expected fiscal Q4 earnings. However, in an environment of high valuations and elevated expectations for artificial intelligence related solutions providers, analysts said that the company's quarterly datacenter business results – which were in line with consensus views – likely proved somewhat disappointing and contributed to the stock's decline. That said, much of the downward pressure on shares came earlier in the year, when a Chinese generative AI startup, DeepSeek, released a free large language model that was cheaper to develop, raising questions about spending on AI infrastructure and the valuations of the biggest players, including chipmakers." An assembly line in a semiconductor factory, with workers at their stations. Marvell Technology, Inc. (NASDAQ:MRVL) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 73 hedge fund portfolios held Marvell Technology, Inc. (NASDAQ:MRVL) at the end of the first quarter, which was 105 in the previous quarter. Marvell Technology, Inc. (NASDAQ:MRVL) reported a record revenue of $1.895 billion in the first quarter of fiscal 2026, marking a 4% sequential increase and strong 63% year-over-year growth. While we acknowledge the potential of Marvell Technology, Inc. (NASDAQ:MRVL) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains. In another article, we covered Marvell Technology, Inc. (NASDAQ:MRVL) and shared the list of stocks Jim Cramer put under the microscope recently. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. While we acknowledge the potential of MRVL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
27 minutes ago
- Yahoo
Cloud Slowdown and Regulatory Challenges Impacted Alphabet's (GOOG) Performance in Q1
Fidelity Investments, an investment management company, recently released its 'Fidelity Dividend Growth Fund' first quarter 2025 investor letter. A copy of the letter can be downloaded here. Fidelity Dividend Growth Fund is a diversified domestic equity strategy with a focus on large-cap core. The portfolio invests in large and mid-cap firms with potential for sustainable dividend growth. The fund's Retail Class shares returned -5.29% in the first quarter, underperforming the -4.27% return of the benchmark S&P 500 index. In the first quarter, the post-election anticipation was replaced by investor concerns regarding the impacts of several actions from the new administration, disruptions to government programs, and rising uncertainty caused by changing policy priorities, particularly in trade tariffs. In addition, you can check the fund's top 5 holdings to know its best picks in 2025. In its first-quarter 2025 investor letter, Fidelity Dividend Growth Fund highlighted stocks such as Alphabet Inc. (NASDAQ:GOOG). Alphabet Inc. (NASDAQ:GOOG), the parent company of Google, offers various platforms and services operating through Google Services, Google Cloud, and Other Bets segments. The one-month return of Alphabet Inc. (NASDAQ:GOOG) was 0.91%, and its shares lost 4.90% of their value over the last 52 weeks. On June 26, 2025, Alphabet Inc. (NASDAQ:GOOG) stock closed at $174.43 per share, with a market capitalization of $2.111 trillion. Fidelity Dividend Growth Fund stated the following regarding Alphabet Inc. (NASDAQ:GOOG) in its Q1 2025 investor letter: "An outsized stake in Alphabet Inc. (NASDAQ:GOOG) detracted as well. The shares returned-18% for the quarter, falling beginning in early February, as the advertising giant and parent of the Google search engine announced quarterly revenue that reflected a slowdown in sales at its cloud-computing and device businesses. Investors were hoping strength in cloud computing would ease the impact of recent weakness in the company's core advertising business. Meanwhile, management said it is meaningfully accelerating investments in data centers that power artificial intelligence. Alphabet also faces regulatory pressure, including a recently opened antitrust probe from the Chinese government." A laptop and phone open to Google's services in an everyday setting. Alphabet Inc. (NASDAQ:GOOG) is in 7th position on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 164 hedge fund portfolios held Alphabet Inc. (NASDAQ:GOOG) at the end of the first quarter which was 174 in the previous quarter. In the first quarter of 2025, Alphabet Inc. (NASDAQ: GOOG) achieved a revenue of $90.2 billion, representing an increase of 12% from Q1 2024. While we acknowledge the potential of Alphabet Inc. (NASDAQ:GOOG) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains. In another article, we covered Alphabet Inc. (NASDAQ:GOOG) and shared the list of best long term growth stocks to invest in. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. While we acknowledge the potential of GOOG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
32 minutes ago
- Yahoo
Vertex Pharmaceuticals Incorporated (VRTX) Benefited from the Launch of its New Drug
Parnassus Investments, an investment management company, released the 'Parnassus Growth Equity Fund' first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, the Fund (Investor Shares) returned -8.59% (net of fees), outperforming the Russell 1000 Growth Index's -9.97% decline. In the first quarter, post-election optimism, driven by reduced regulation and a business-friendly environment, drifted away to concerns over fiscal and tariff uncertainties, which increased volatility and raised fears of a recession. In addition, please check the fund's top five holdings to know its best picks in 2025. In its first-quarter 2025 investor letter, Parnassus Growth Equity Fund highlighted stocks such as Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is a biotechnology company focusing on developing and commercializing therapies for treating cystic fibrosis (CF). The one-month return of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) was 0.31%, and its shares lost 5.40% of their value over the last 52 weeks. On June 26, 2025, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stock closed at $443.40 per share, with a market capitalization of $113.864 billion. Parnassus Growth Equity Fund stated the following regarding Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) in its Q1 2025 investor letter: "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stock gained on optimism for the launch of its new drug Journavx, a non-opioid painkiller for acute pain and the first new class of pain medicine to be approved by the FDA in more than 20 years. Vertex also benefited from continued growth in its cystic fibrosis business." A pharmacist delivering a specific medication to a patient in a specialty pharmacy. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 60 hedge fund portfolios held Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) at the end of the first quarter, which was 68 in the previous quarter. While we acknowledge the potential of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains. In another article, we covered Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and shared the list of best biotech stocks to invest in. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. While we acknowledge the potential of VRTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
